Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation

The objective of this study was to externally validate a new dosing scheme for busulfan. Thirty-seven adult patients who received busulfan as conditioning therapy for hematopoietic stem cell transplantation (HCT) participated in this prospective study. Patients were randomized to receive intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Sang-Heon, Lee, Jung-Hee, Lim, Hyeong-Seok, Lee, Kyoo-Hyung, Kim, Dae-Young, Choe, Sangmin, Bae, Kyun-Seop, Lee, Je-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860366/
https://www.ncbi.nlm.nih.gov/pubmed/27162478
http://dx.doi.org/10.4196/kjpp.2016.20.3.245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860366/
https://www.ncbi.nlm.nih.gov/pubmed/27162478
http://dx.doi.org/10.4196/kjpp.2016.20.3.245

Ejemplares similares